Janssen Inc. v. Sandoz Canada Inc., 2022 FC 715
| Jurisdiction | Federal Jurisdiction (Canada) |
| Court | Federal Court (Canada) |
| Citation | 2022 FC 715 |
| Date | 31 May 2022 |
-
- This document is available in original version only for vLex customers
View this document and try vLex for 7 days - TRY VLEX
- This document is available in original version only for vLex customers
6 practice notes
-
UPL NA Inc. v. AgraCity Crop & Nutrition Ltd., 2022 FC 1422
...date and adopt the proper temporal frame of reference to analyze the issues, without hindsight [see Janssen Inc v Sandoz Canada Inc, 2022 FC 715 at para 71]. [90] Expert witnesses assist the Court by opining on the qualifications, relevant experience and knowledge of the Skilled Person and ......
-
Sandoz Canada Inc. v. Janssen Inc., 2023 FCA 221
... Respondents REASONS FOR JUDGMENT LOCKE J.A. I. Overview [1] This appeal concerns a decision of the Federal Court (2022 FC 715, per Justice Christine M. Pallotta) that dismissed allegations by the appellant, Sandoz Canada Inc., that Canadian Patent No. 2,659,770 (the Pat......
-
2023 Year In Review: Life Sciences In Canada
...decision ( 2002 SCC 77 ) and Eli Lilly v. Novopharm ( 2010 FCA 197 ). The Court of Appeal, in alignment with the Federal Court's ruling in 2022 FC 715, upheld that the utility of Janssen's CA2,659,770 combination patent (macitentan and a PDE5 inhibitor to treat pulmonary arterial hypertensi......
-
Promise Me No Promises? The Five-year Anniversary Of The Supreme Court's AstraZeneca Decision
...at paras 219, 240-241. 38. Aux Sable at paras 56-69. 39. Aux Sable at paras 74. 40. Eli Lilly v Apotex, 2020 FC 814. 41. Janssen v Sandoz, 2022 FC 715 at para 42. Seedlings v Pfizer, 2021 FCA 154. Read the original article on GowlingWLG.com The content of this article is intended to provide......
Request a trial to view additional results
2 cases
-
UPL NA Inc. v. AgraCity Crop & Nutrition Ltd., 2022 FC 1422
...date and adopt the proper temporal frame of reference to analyze the issues, without hindsight [see Janssen Inc v Sandoz Canada Inc, 2022 FC 715 at para 71]. [90] Expert witnesses assist the Court by opining on the qualifications, relevant experience and knowledge of the Skilled Person and ......
-
Sandoz Canada Inc. v. Janssen Inc., 2023 FCA 221
... Respondents REASONS FOR JUDGMENT LOCKE J.A. I. Overview [1] This appeal concerns a decision of the Federal Court (2022 FC 715, per Justice Christine M. Pallotta) that dismissed allegations by the appellant, Sandoz Canada Inc., that Canadian Patent No. 2,659,770 (the Pat......
4 firm's commentaries
-
2023 Year In Review: Life Sciences In Canada
...decision ( 2002 SCC 77 ) and Eli Lilly v. Novopharm ( 2010 FCA 197 ). The Court of Appeal, in alignment with the Federal Court's ruling in 2022 FC 715, upheld that the utility of Janssen's CA2,659,770 combination patent (macitentan and a PDE5 inhibitor to treat pulmonary arterial hypertensi......
-
Promise Me No Promises? The Five-year Anniversary Of The Supreme Court's AstraZeneca Decision
...at paras 219, 240-241. 38. Aux Sable at paras 56-69. 39. Aux Sable at paras 74. 40. Eli Lilly v Apotex, 2020 FC 814. 41. Janssen v Sandoz, 2022 FC 715 at para 42. Seedlings v Pfizer, 2021 FCA 154. Read the original article on GowlingWLG.com The content of this article is intended to provide......
-
Federal Court finds a combination therapy patent valid and infringed
...can be useful to treat these diseases by effecting vasodilation. Link to decision: Janssen Inc. v Sandoz Canada Inc., 2022 FC 715>(the Regulations). The Court dismissed allegations that the asserted patent claims were invalid for obviousness, lack of utility, overbreadth, and insufficiency ......
-
Federal Court Finds Janssen's Macitentan Combination Therapy Patent Valid
...of Canadian Patent No. 2,659,770 (the 770 Patent) valid and granted a declaration of infringement: Janssen Inc v Sandoz Canada Inc, 2022 FC 715. Macitentan belongs to a class of drugs known as endothelin receptor antagonists (ERAs). Janssen markets macitentan in Canada for the treatment of ......